MITSUI & CO. GLOBAL INVESTMENT, INC.
MITSUI & CO. GLOBAL INVESTMENT, INC. is a Seed, Series A, Series B and Series C+ fund in the US, Europe and Asia writing $1M–$50M checks into Fintech, Healthcare, agtech, foodtech, technology and industrials.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Fintech, Healthcare, agtech, foodtech, technology, industrials
- Check size
- $1M–$50M
- Invests in
- US-wide, Europe, Asia
- Actively investing
- Yes
- Founded
- 2001
Thesis
Mitsui & Co. Global Investment, Inc. (MGI), established in 2001 as a subsidiary of Mitsui & Co., Ltd., is a venture capital firm focused on supporting innovative entrepreneurs and scaling companies globally. MGI provides capital and strategic guidance, leveraging its parent company's extensive global network and industrial expertise. The firm's investment strategy is sector-agnostic within technology, industrials, and healthcare, with specific focus areas including biotech, digital health, agtech, foodtech, fintech, and climatech. MGI engages in early-to-growth stage investing, from seed funding to growth and pre-IPO investments. The typical investment size ranges from $1 million to $50 million, though deal sizes can vary. MGI has a broad geographic scope, investing in companies across North America, Europe, and Asia. While specific AUM is not disclosed, a related entity has an investment ticket size of $10-50 million and focuses on Series A, Series B, and Late Stage investments.
Common questions
Does MITSUI & CO. GLOBAL INVESTMENT, INC. invest at the Seed stage?
Yes. MITSUI & CO. GLOBAL INVESTMENT, INC. lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does MITSUI & CO. GLOBAL INVESTMENT, INC. write?
MITSUI & CO. GLOBAL INVESTMENT, INC. writes $1M–$50M checks.
Where does MITSUI & CO. GLOBAL INVESTMENT, INC. invest?
MITSUI & CO. GLOBAL INVESTMENT, INC. invests in the US, Europe and Asia.